Identification of therapeutic targets applicable to clinical strategies in ovarian cancer

BACKGROUND: shRNA-mediated lethality screening is a useful tool to identify essential targets in cancer biology. Ovarian cancer (OC) is extremely heterogeneous and most cases are advanced stages at diagnosis. OC has a high response rate initially, but becomes resistant to standard chemotherapy. We p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Marianne K., Caplen, Natasha, Chakka, Sirisha, Hernandez, Lidia, House, Carrie, Pongas, Georgios, Jordan, Elizabeth, Annunziata, Christina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997769/
https://www.ncbi.nlm.nih.gov/pubmed/27558154
http://dx.doi.org/10.1186/s12885-016-2675-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997769/
https://www.ncbi.nlm.nih.gov/pubmed/27558154
http://dx.doi.org/10.1186/s12885-016-2675-5

Ejemplares similares